-+ 0.00%
-+ 0.00%
-+ 0.00%

Recently, the State Drug Administration approved the launch of the Class 1 innovative drug Stogilene Malate tablets declared by Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd. This drug is suitable for essential hypertension and provides new clinical treatment options.

Zhitongcaijing·12/09/2025 10:41:06
Listen to the news
Recently, the State Drug Administration approved the launch of the Class 1 innovative drug Stogilene Malate tablets declared by Shanghai Shangyao Xinyi Pharmaceutical Co., Ltd. This drug is suitable for essential hypertension and provides new clinical treatment options.